Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Phytochemistry ; 95: 436-44, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23890760

ABSTRACT

Blueberry consumption is associated with health benefits contributing to a reduced risk for cardiovascular disease, diabetes and cancer. The aim of this study was to determine the anthocyanin profile of blueberry extracts and to evaluate their effects on B16-F10 metastatic melanoma murine cells. Seven blueberry cultivars cultivated in Romania were used. The blueberry extracts were purified over an Amberlite XAD-7 resin and a Sephadex LH-20 column, in order to obtain the anthocyanin rich fractions (ARF). The antioxidant activity of the ARF of all cultivars was evaluated by ABTS, CUPRAC and ORAC assays. High performance liquid chromatography followed by electrospray ionization mass spectrometry (HPLC-ESI-MS) was used to identify and quantify individual anthocyanins. The anthocyanin content of tested cultivars ranged from 101.88 to 195.01 mg malvidin-3-glucoside/100g fresh weight. The anthocyanin rich-fraction obtained from cultivar Torro (ARF-T) was shown to have the highest anthocyanin content and antioxidant activity, and inhibited B16-F10 melanoma murine cells proliferation at concentrations higher than 500 µg/ml. In addition, ARF-T stimulated apoptosis and increased total LDH activity in metastatic B16-F10 melanoma murine cells. These results indicate that the anthocyanins from blueberry cultivar could be used as a chemopreventive or adjuvant treatment for metastasis control.


Subject(s)
Anthocyanins/therapeutic use , Antineoplastic Agents, Phytogenic/therapeutic use , Antioxidants/therapeutic use , Blueberry Plants/chemistry , Melanoma, Experimental/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Animals , Anthocyanins/isolation & purification , Anthocyanins/pharmacology , Antineoplastic Agents, Phytogenic/isolation & purification , Antineoplastic Agents, Phytogenic/pharmacology , Antioxidants/isolation & purification , Antioxidants/pharmacology , Apoptosis/drug effects , Cell Proliferation/drug effects , Glucosides/isolation & purification , Glucosides/pharmacology , Glucosides/therapeutic use , L-Lactate Dehydrogenase/metabolism , Melanoma, Experimental/metabolism , Mice , Plant Extracts/pharmacology , Species Specificity
2.
J Med Food ; 15(8): 700-6, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22846076

ABSTRACT

The present study evaluates the antioxidant activity of two Aronia melanocarpa cultivars-Viking and Aron-and of Aronia prunifolia hybrid in relationship with their phytochemical composition regarding the contents of total phenolics, flavonoids, procyanidins, and monomeric anthocyanins. The antioxidant capacity of the mentioned extracts of chokeberries was evaluated through five complementary assays: 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid), H(2)O(2) scavenging potential, oxygen radical absorbance capacity, ferric reducing antioxidant power, and cupric ion reducing antioxidant capacity. A. prunifolia hybrid was found to have the highest antioxidant activity and to be the richest in polyphenols, procyanidins, and anthocyanins compared with the A. melanocarpa cultivars. A good correlation was observed between antioxidant activity and total procyanidin and anthocyanin content. Cyanidin glycosides inhibited HeLa human cervical tumor cell proliferation and increased generation of reactive oxygen species after 48 h of treatment, suggesting that they could be responsible for the antiproliferative activity. These results may be significant for industry concerning food quality and disease prevention.


Subject(s)
Anthocyanins/pharmacology , Antioxidants/pharmacology , Cytotoxins/pharmacology , Photinia/chemistry , Plant Extracts/pharmacology , Anthocyanins/analysis , Antioxidants/analysis , Cell Line, Tumor , Cell Survival/drug effects , Cytotoxins/analysis , Female , Fruit/chemistry , HeLa Cells , Humans , Plant Extracts/analysis , Reactive Oxygen Species/metabolism , Uterine Cervical Neoplasms/drug therapy , Uterine Cervical Neoplasms/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...